Publication date: Available online 4 August 2020Source: Allergology InternationalAuthor(s): Mari Nakanishi, Risa Tamagawa-Mineoka, Yukiyasu Arakawa, Koji Masuda, Norito Katoh
Wed Aug 05, 2020 13:20
Abstract Background Allergic asthma is characterized by type 2 inflammation. We have shown the presence of increased type 2 inflammation in patients with severe asthma and those with frequent exacerbations. However, it is not known whether increased type 2 inflammation drives asthma exacerbations. This study aims to determine Th2 immune parameters in patients presenting to the emergency department (ED) with an acute asthma exacerbation and correlate these parameters with clinical and physiological...
Tue Aug 04, 2020 11:25
Current guidelines do not recommend performing aeroallergen skin prick testing (SPT) in chronic spontaneous urticaria (CSU).
Tue Aug 04, 2020 03:00
The incidence of penicillin allergy has been widely exaggerated; while up to 10% of patients report penicillin allergies to their physicians, over 90% of these individuals can in fact tolerate penicillins when challenged.1 Despite this reality, many physicians are reluctant to refer patients with self-reported penicillin allergy for testing, often out of concern for the cost-effectiveness of allergy testing relative to simple avoidance. Similarly, many allergists do not offer allergy testing to penicillin...
Wed Aug 05, 2020 03:00
Abstract Background Allergy to Peanuts ImPacting Emotions And Life (APPEAL‐1) was a recent European multi‐country questionnaire survey that highlighted the negative impacts of peanut allergy (PA) on quality of life. A follow‐on qualitative study, APPEAL‐2, further assessed the burden of PA and associated coping strategies through semi‐structured interviews. Objective To gain qualitative insight on the strategies used to cope with and manage PA and the impact of these strategies on the quality...
Wed Aug 05, 2020 14:25
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with periods of flares and remission. Designing personalised treatment strategies for AD is challenging, given the apparent unpredictability and large variation in AD symptoms and treatment responses within and across individuals. Better prediction of AD severity over time for individual patients could help to select optimum timing and type of treatment for improving disease control. Objective We aimed to...
Tue Aug 04, 2020 20:13
Publication date: Available online 5 August 2020Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Benjamin C. Remington, W. Marty Blom, Boris Bassa, Stef J. Koppelman
Wed Aug 05, 2020 22:06
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.